IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Insys Therapeutics Inc New COM New

CUSIP: 045824V29 | 1 institutional holders

Quarters

Q3 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2018

ETF Managers Group, LLC1,204,784
0.0% of portfolio›$12.0K
StyleTurnoverLocationFiled
ETF Managers Group, LLC
1,204,784$12.0K0.0%N/AN/ASummit, NJ2018-11-14